Webinars

To improve trial recruitment, engagement, and retention, and to increase the likelihood that trials reflect what matters most to patients, regulatory authorities increasingly point to methods for incorporating patient voice in the development of new therapeutics, specifically as part of clinical trials.

Our present healthcare system focuses on treating people when they are ill rather than keeping them healthy. We have been using big data and remote monitoring approaches to monitor people while they are healthy to keep them that way and detect disease at its earliest moment presymptomatically. We use advanced multiomics technologies (genomics, immunomics, transcriptomics, proteomics, metabolomics, microbiomics) as well as wearables and microsampling for actively monitoring health. Following a group of 109 individuals for up to 13 years revealed numerous major health discoveries covering cardiovascular disease, oncology, metabolic health and infectious disease. We have also found that individuals have distinct aging patterns that can be measured in an actionable period of time. Finally, we have used wearable devices for early detection of infectious disease, including COVID-19 as well as microsampling for monitoring and improving lifestyle. We believe that advanced technologies have the potential to transform healthcare and keep people healthy.

Market access is the bridge between clinical and commercial functions, and plays a pivotal role in product launch. Success in market access is defined by the outcome of payer decisions – whether nationally or regionally. While measuring global market access performance has been on the agenda for some time, understanding success is becoming a priority at board and leadership level.

From real-world data to social media, there is more information available to medical affairs teams than ever before. In theory, it should be easier than ever to keep the business aligned with patient and customer needs, yet in practice, the process of insights management is rarely optimized across the organization.

The L7|LIVE SF seminar will explore the ways in which digital technologies, such as unified platforms, are revolutionizing the biotech and life science industries, transforming business models, breaking down data silos, reducing turnaround times, and creating more consistent and reproducible processes. Our panel of experts will share their insights and experiences on these needed cutting-edge technologies and the trends laying the foundation for the future of life sciences.

Health systems are reimagining the hospital of the future. New technologies like real-time asset tracking, artificial intelligence, and applied virtual/augmented reality will be integral to delivering next-generation, interventional care with real-time insights at the point of care. But an infrastructure transformation will be necessary to deliver those capabilities and power innovation roadmaps.

Join Jonathan Edelheit, Chairman and Co-founder of the Corporate Wellness Association as he talks about the Certified Corporate Wellness Specialist and find out if it is the right certification for you. The Certified Corporate Wellness Specialist program is designed to help organizations improve the health and well-being of their employees while also reducing healthcare costs. The program includes 11 modules that cover topics such as leadership, culture, cost savings, mental health, wellness technology, employee well-being, diversity, equity, and inclusion. It also covers the essentials of program design, delivery, and evaluation.

A panel discussion will examine how connected communities using data-driven, virtual and automated technologies are advancing and refining population health strategies. Discover ways health leaders can advance interoperability, intelligent processing and data security so their organizations can respond to consumer demands and take on risk.